INHIBITION OF HEPARANASE-MEDIATED DEGRADATION OF EXTRACELLULAR-MATRIX HEPARAN-SULFATE BY NON-ANTICOAGULANT HEPARIN SPECIES
- 1 August 1987
- journal article
- research article
- Vol. 70 (2) , 551-557
Abstract
Incubation of human platelets, human neutrophils, or highly metastatic mouse lymphoma cells with sulfate-labeled extracellular matrix (ECM) results in heparanase-mediated release of labeled heparan sulfate cleavage fragments (0.5 < Kav < 0.85 on Sepharose 6B). This degradation was inhibited by native heparin both when brought about by intact cells or their released heparanase activity. Degradation of heparan sulfate in ECM may facilitate invasion of normal and malignant cells through basement membranes. The present study tested the heparanase inhibitory effect of nonanticoagulant species of heparin that might be of potential use in preventing heparanase mediated extravasation of bloodborne cells. For this purpose, we prepared various species of low-sulfated or low-mol-wt heparins, all of which exhibited < 7% of the anticoagulant activity of native heparin. N-sulfate groups of heparin are necessary for its heparanase inhibitory activity but can be substituted by an acetyl group provided that the O-sulfate groups are retained. O-sulfate groups could be removed provided that the N positions were resulfated. Total desulfation of heparin abolished its heparanase inhibitory activity. Heparan sulfate was a 25-fold less potent heparanase inhibitor than native heparin. Efficiency of low-mol-wt heparins to inhibit degradation of heparan sulfate in ECM decreased with their main molecular size, and a synthetic pentasaccharide, representing the binding site to antithrombin III, was devoid of inhibitory activity. Similar results were obtained with heparanase activities released from platelets, neutrophils, and lymphoma cells. We propose that heparanase inhibiting nonanticoagulant heparins may interfere with dissemination of bloodborne tumor cells and development of experimental autoimmune diseases.This publication has 17 references indexed in Scilit:
- The Inhibitory Effect of Heparin and Related Glycosaminoglycans on Neutrophil ChemotaxisThrombosis and Haemostasis, 1984
- Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase.Journal of Biological Chemistry, 1984
- Interaction of T lymphocytes and macrophages with cultured vascular endothelial cells: Attachment, invasion, and subsequent degradation of the subendothelial extracellular matrixJournal of Cellular Physiology, 1984
- Glycosaminoglycans synthesized by cultured bovine corneal endothelial cellsJournal of Cellular Physiology, 1983
- Heparan Sulfate Degradation: Relation to Tumor Invasive and Metastatic Properties of Mouse B16 Melanoma SublinesScience, 1983
- LYMPHOMA CELL-MEDIATED DEGRADATION OF SULFATED PROTEOGLYCANS IN THE SUBENDOTHELIAL EXTRACELLULAR-MATRIX - RELATIONSHIP TO TUMOR-CELL METASTASIS1983
- Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase.Journal of Biological Chemistry, 1982
- Platelet interaction with the extracellular matrix produced by cultured endothelial cells: A model to study the thrombogenicity of isolated subendothelial basal laminaThrombosis Research, 1982
- Substrate Specificity of a Heparan Sulfate-Degrading Endoglucuronidase from Human PlacentaHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1979
- EFFECTS OF ANTICOAGULANTS AND OTHER DRUGS ON CELLULAR AND CUTANEOUS REACTIONS TO ANTIGEN IN GUINEA-PIGS WITH DELAYED-TYPE HYPERSENSITIVITY1965